DOP proposed to bring medical devices under Drug Price Control Order

New Delhi
To control the high prices of medical devices such as stents and implants, Department of Pharmaceuticals has proposed to Health Ministry to bring them under the Drug Price Control Order. “For the first time the Department of Pharmaceuticals has proposed to the Health Ministry for bringing medical devices and stents under the drug price control order. As per the procedure Health Ministry will prepare the National List of Essential Devices which will be then enforced by the National Pharmaceutical Pricing Authority (NPPA). Last year, a task force on medical devices was constituted under the Chairmanship of Secretary, Department of Pharmaceuticals and it had recommended a separate price control order for medical devices by putting them under the Essential Commodities Act. “…the medical devices may be included separately from drugs in the Essential Commodities Act and regulated under a separate Medical Devices (Price Control) Order (MDPCO),” the report of the task force had said.

  • Related Posts

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    The officials identified the substance as Alprazolam manufactured illegally at the lab. HYDERABAD: In one of the largest such seizures in recent times, the Narcotics Control Bureau (NCB), Hyderabad, raided…

    Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

    New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Commissioner FDA reviews enforcement measures

    Commissioner FDA reviews enforcement measures

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices